Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

GTHX

G1 Therapeutics (GTHX)

G1 Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GTHX
DateTimeSourceHeadlineSymbolCompany
07/19/202110:03AMDow Jones NewsG1 Therapeutics Gets Fast Track Designation for Breast Cancer TreatmentNASDAQ:GTHXG1 Therapeutics Inc
07/19/20219:20AMGlobeNewswire Inc.G1 Therapeutics Receives Fast Track Designation from U.S. Food and Drug Administration for COSELA™ (Trilaciclib) in Combina...NASDAQ:GTHXG1 Therapeutics Inc
07/15/20214:05PMGlobeNewswire Inc.Viridian Therapeutics Appoints Jennifer Moses, CPA to the Board of Directors and as Chair of the Audit CommitteeNASDAQ:GTHXG1 Therapeutics Inc
07/15/20214:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
07/02/20217:30PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
07/02/20214:56PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTHXG1 Therapeutics Inc
07/02/20214:07PMEdgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:GTHXG1 Therapeutics Inc
06/30/20214:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:25PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/21/20214:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/18/20219:00AMGlobeNewswire Inc.G1 Therapeutics Announces Addition of Alicia Secor to Board of DirectorsNASDAQ:GTHXG1 Therapeutics Inc
06/17/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
06/16/20217:00AMGlobeNewswire Inc.G1 Therapeutics to Present at the 2021 Raymond James Human Health Innovation ConferenceNASDAQ:GTHXG1 Therapeutics Inc
06/14/20217:00AMGlobeNewswire Inc.G1 Therapeutics Initiates PRESERVE 3, A Randomized Phase 2 Study of COSELA™ (trilaciclib) in Bladder CancerNASDAQ:GTHXG1 Therapeutics Inc
06/04/20214:01PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
06/04/20219:02AMGlobeNewswire Inc.G1 Therapeutics Presents Phase 1 Data at ASCO Describing Favorable Safety Profile and Evidence of Antitumor Activity of Rinto...NASDAQ:GTHXG1 Therapeutics Inc
06/04/20219:01AMGlobeNewswire Inc.G1 Therapeutics Presents Data on COSELA™ (trilaciclib) at ASCO on Potential Immune Activation in Patients with Newly Diagno...NASDAQ:GTHXG1 Therapeutics Inc
05/19/20215:01PMGlobeNewswire Inc.G1 Therapeutics Announces Upcoming Data at the American Society of Clinical Oncology (ASCO) Virtual 2021 Annual MeetingNASDAQ:GTHXG1 Therapeutics Inc
05/17/20217:00AMGlobeNewswire Inc.G1 Therapeutics Presents Two Posters at ISPOR Describing the Estimated Economic Impact of Treating Myelosuppression Among Pat...NASDAQ:GTHXG1 Therapeutics Inc
05/13/20214:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
05/13/20216:20AMBusiness WireGenetron Health Announces Strategic Partnership with Siemens Healthineers to Promote Precision Oncology for Lung CancerNASDAQ:GTHXG1 Therapeutics Inc
05/11/20214:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTHXG1 Therapeutics Inc
05/10/20216:50AMGlobeNewswire Inc.G1 Therapeutics Initiates Randomized Double Blind Placebo Controlled Phase 2 Study of COSELA™ (trilaciclib) in Non-Small Ce...NASDAQ:GTHXG1 Therapeutics Inc
05/07/20214:01PMGlobeNewswire Inc.G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:GTHXG1 Therapeutics Inc
05/05/20215:17PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTHXG1 Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:GTHX